Obesity

Showing NaN - NaN of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in Atlanta (PATH Intervention, Control Group, Physical activity tracker)

Not yet recruiting
  • Obesity
  • PATH Intervention
  • +3 more
  • Atlanta, Georgia
    Emory University
Nov 7, 2023

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity Trial in Atlanta, Oklahoma City (Tirzepatide, Placebo)

Not yet recruiting
  • Obesity
  • Atlanta, Georgia
  • +1 more
Jan 17, 2023

Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Sleep Apnea
  • Obesity
  • Riverside, California
  • +66 more
Jan 23, 2023

Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Heart Failure With Preserved Ejection Fraction
  • Huntsville, Alabama
  • +144 more
Jan 18, 2023

Surgical Site Infection, Obesity, Diabetes Trial in United States (Negative Pressure Wound Therapy)

Completed
  • Surgical Site Infection
  • +3 more
  • Negative Pressure Wound Therapy
  • Atlanta, Georgia
  • +4 more
Nov 17, 2022

Obesity Trial in United States

Recruiting
  • Obesity
    • Marina Del Rey, California
    • +15 more
    Oct 3, 2022

    B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Obesity
    • IDEAL2 Intervention
    • Los Angeles, California
    • +15 more
    Jun 23, 2022

    Colon Cancer, Obesity Trial in Atlanta (Experimental: High Fiber Diet (HFD), Healthy American Diet)

    Recruiting
    • Colon Cancer
    • Obesity
    • Experimental: High Fiber Diet (HFD)
    • Healthy American Diet
    • Atlanta, Georgia
      Rollins School of Public Health, Emory University
    Jun 8, 2022

    Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Active, not recruiting
    • Type 2 Diabetes
    • +2 more
    • Birmingham, Alabama
    • +74 more
    Apr 18, 2022

    Diabetes Type 2, Diabetes, Obesity Trial in Atlanta, Johns Creek (Cryoablation of the Vagus Nerve, Lifestyle Intervention)

    Completed
    • Diabetes Type 2
    • +2 more
    • Cryoablation of the Vagus Nerve
    • Lifestyle Intervention
    • Atlanta, Georgia
    • +4 more
    Mar 25, 2022

    Overweight, Obesity Trial in United States

    Recruiting
    • Overweight
    • Obesity
      • Little Rock, Arkansas
      • +27 more
      Feb 11, 2022

      Gastrectomy, Obesity Trial in Atlanta (ViSiGiĀ® 3D suction calibration device, Esophagogastroduodenoscopy (EGD) calibration)

      Active, not recruiting
      • Gastrectomy
      • Obesity
      • ViSiGiĀ® 3D suction calibration device
      • Esophagogastroduodenoscopy (EGD) calibration
      • Atlanta, Georgia
        Emory University Hospital Midtown
      Feb 9, 2022

      Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

      Completed
      • Obesity
      • Overweight
      • Semaglutide 1.0 mg
      • +3 more
      • Buena Park, California
      • +146 more
      Nov 8, 2021

      Autism Spectrum Disorder, Obesity Trial in Atlanta (The Changing Health in Autism through Nutrition, Getting fit and Expanding

      Completed
      • Autism Spectrum Disorder
      • Obesity
      • The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) Program
      • Atlanta, Georgia
        Emory University
      Dec 2, 2020

      Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

      Completed
      • Cardiovascular Disease
      • +4 more
      • Lorcaserin hydrochloride
      • Placebo
      • Alexander City, Alabama
      • +498 more
      Jun 27, 2019

      Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

      Unknown status
      • Endometrial Clear Cell Adenocarcinoma
      • +6 more
      • 3-Dimensional Conformal Radiation Therapy
      • +7 more
      • Birmingham, Alabama
      • +539 more
      Mar 8, 2019

      Metabolism and Nutrition Disorder, Obesity Trial in United States (liraglutide, )

      Completed
      • Metabolism and Nutrition Disorder
      • Obesity
      • Anaheim, California
      • +8 more
      Mar 14, 2019

      Obesity, Colorectal Carcinoma Trial in Atlanta (behavioral, device, other)

      Completed
      • Obesity
      • Colorectal Carcinoma
      • Legume diet group
      • +3 more
      • Atlanta, Georgia
      • +1 more
      Jan 24, 2019

      Obesity Trial in Atlanta, Johns Creek (Cryoablation)

      Completed
      • Obesity
      • Cryoablation
      • Atlanta, Georgia
      • +2 more
      Oct 30, 2018

      Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)

      Completed
      • Obesity
      • S-2367 Placebo
      • +4 more
      • Birmingham, Alabama
      • +39 more
      May 9, 2018

      Obesity Trial in United States (S-2367 Placebo, S-2367 800 mg, S-2367 1600 mg)

      Completed
      • Obesity
      • S-2367 Placebo
      • +3 more
      • Mobile, Alabama
      • +37 more
      May 8, 2018

      Obesity Trial in United States (S-2367 (velneperit))

      Completed
      • Obesity
      • S-2367 (velneperit)
      • Birmingham, Alabama
      • +72 more
      Apr 26, 2018

      Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

      Completed
      • Metabolism and Nutrition Disorder
      • Obesity
      • Vestavia Hills, Alabama
      • +160 more
      Dec 6, 2017